Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Neuroimage. 2019 Jun 28;200:302–312. doi: 10.1016/j.neuroimage.2019.06.065

Table I.

Subject Demographics and Relevant Clinical Information.

Measure AD Cohort PSP Cohort
AD Control Statistics PSP Control Statistics
N 30 32 - 26 31 -
Sex (17M/13F) (12M/20F) χ2=2.285; p=0.203 (15M/11F) (12M/19F) χ2=0.076; p=0.783
Age (years) 73.99 (8.37) 72.73 (5.98) F=3.774; p=0.494 69.88 (6.38) 63.23 (10.08) F=7.57; p=0.004
MoCA 17.72 (4.66) 26.06 (2.45) F=7.793; p<0.001 20.23 (5.33) 26.96 (1.92) F=35.151; p<0.001

Data are either count or mean (±SD). Abbreviations: AD, Alzheimer’s disease; PSP, Progressive Supranuclear Palsy; N, Number; M, Male; F, Female; MoCA, Montreal Cognitive Assessment